Two novel rhodium(III) complexes,
namely, [RhIII(X)Cl3] (X = 2 2,6-bis((4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-1H-4,7-methanoindazol-3-yl)pyridine or 2,6-bis((4S,7R)-1,7,8,8-tetramethyl-4,5,6,7-tetrahydro-1H-4,7-methanoindazol-3-yl)pyridine), were synthesized from
camphor derivatives of a bis(pyrazolylpyridine), tridentate nitrogen-donor
chelate system, giving [RhIII(H2L*)Cl3] (1a) and [RhIII(Me2L*)Cl3] (1b). A rhodium(III) terpyridine (terpy) ligand
complex, [RhIII(terpy)Cl3] (1c),
was also synthesized. By single-crystal X-ray analysis, 1b crystallizes in an orthorhombic P212121 system, with two molecules in the asymmetric
unit. Tridentate coordination by the N,N,N-donor localizes the central
nitrogen atom close to the rhodium(III) center. Compounds 1a and 1b were reactive toward l-methionine (l-Met), guanosine-5′-monophosphate (5′-GMP), and
glutathione (GSH), with an order of reactivity of 5′-GMP >
GSH > l-Met. The order of reactivity of the RhIII complexes was: 1b> 1a > 1c. The RhIII complexes showed affinity for calf thymus
DNA and bovine serum albumin by UV–vis and emission spectral
studies. Furthermore, 1b showed significant in vitro
cytotoxicity against human epithelial colorectal carcinoma cells.
Since the RhIII complexes have similar coordination modes,
stability differences were evaluated by density functional theory
(DFT) calculations (B3LYP(CPCM)/LANL2DZp). With (H2L*)
and (terpy) as model ligands, DFT calculations suggest that both tridentate
ligand systems have similar stability. In addition, molecular docking
suggests that all test compounds have affinity for the minor groove
of DNA, while 1b and 1c have potential for
DNA intercalation.